Collectively, these findings suggest that high expression of PRP19 might impede B cell infiltration in HCC tissues, and the levels of PRP19 and B cell marker CD20 are associated with the prognostic outcomes of HCC patients. This evidence concerns the gene PRPF19 and hepatocellular carcinoma.